The observed increase in PON1 activity levels would in this manner reflect a defence mechanism to prevent further hepatometabolic manifestations that lead to the advancement of obesity to NAFLD/NASH. Here, PON1 is linked to metabolic dysfunction-associated steatotic liver disease.